4.6 Article

Atrial natriuretic peptide administered just prior to reperfusion limits infarction in rabbit hearts

期刊

BASIC RESEARCH IN CARDIOLOGY
卷 101, 期 4, 页码 311-318

出版社

SPRINGER HEIDELBERG
DOI: 10.1007/s00395-006-0587-2

关键词

atrial natriuretic peptide; guanylyl cyclase; ischemia/reperfusion; mK(ATP) channels; protein kinase G

向作者/读者索取更多资源

We investigated whether atrial natriuretic peptide (ANP) given just prior to reperfusion reduces infarction in rabbit hearts and whether protection is related to activation of protein kinase G (PKG). Isolated rabbit hearts were subjected to a 30-min period of regional ischemia; treated hearts received a 20-min infusion of ANP (0.1 mu M) starting 5 min before 2 h of reperfusion. ANP infusion decreased infarction from 31.5 +/- 2.4% of the risk zone in untreated hearts to 12.5 +/- 2.0% (P < 0.001). To explore mechanisms of protection ischemic hearts were treated simultaneously with ANP and isatin, a blocker of the natriuretic peptide receptor, shortly before reperfusion. ANP's protective effect was aborted (36.8 +/- 2.9% infarction). There is no acceptable blocker of protein kinase G that can be used in intact organs. However, 8-(4-chlorophenylthio)-guanosine 3', 5'-cyclic monophosphate (10 mu M), a cell-permeable cGMP analog that directly activates PKG, was infused from 5 min before to 15 min after reperfusion. The PKG activator mimicked ANP's protection with only 18.2 +/- 3.6% infarction (P < 0.001). 5-Hydroxyde-canoate (5-HD), a putative mitochondrial K-ATP channel (mK(ATP)) inhibitor, abrogated ANP's protection (34.4 +/- 2.6% infarction). Unexpectedly, 1H-[1,2,4]oxadiazole- [4,3-a]quinoxalin-1-one (ODQ), a blocker of soluble guanylyl cyclase also prevented ANP's infarct-sparing effect. It is unclear whether this observation implicated participation of soluble guanylyl cyclase in the mechanism or simply a lack of selectivity of ODQ. Finally the reperfusion injury salvage kinases (RISK), phosphatidylinositol 3-kinase and extracellular signal-regulated kinase, were implicated in ANP's mechanism since either wortmannin or PD98059 infused at reperfusion prevented ANP's infarct-sparing effect. ANP administered just prior to reperfusion protects hearts against infarction, likely by activation of PKG, opening of mK(ATP), and stimulation of downstream kinases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据